
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
HLN
HLN: Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
moreShow HLN Financials
Recent trades of HLN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HLN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on HLN's company Twitter account
Number of mentions of HLN in WallStreetBets Daily Discussion
Recent insights relating to HLN
Recent picks made for HLN stock on CNBC
ETFs with the largest estimated holdings in HLN
Flights by private jets registered to HLN